Prosecution Insights
Prosecution Insights
134 pending office actions • 53 art units • 118 examiners • 0 of 134 (0%) have an AI response strategy ready • 132 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 43 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 43 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (1%) |
| §101 + other | 7 (5%) |
| §103 only | 40 (30%) |
| §102 only | 5 (4%) |
| §112 only | 13 (10%) |
| Double-patenting only | 6 (4%) |
| Double-patenting + other | 13 (10%) |
| Multi-statute (no §101) | 45 (34%) |
| No statute on record | 3 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUYNH, PHUONG N | 3 | 65.7% | +53.6% |
| SKELDING, ZACHARY S | 3 | 59.8% | +41.0% |
| TECCO, ANDREW M | 2 | 65.2% | +24.9% |
| BOUCHELLE, LAURA A | 2 | 80.3% | +10.4% |
| BASQUILL, SEAN M | 2 | 38.8% | +21.6% |
| BOSQUES, EDELMIRA | 2 | 62.9% | +20.6% |
| LOUNTOS, GEORGE THEMISTOCLIS | 2 | 33.3% | +0.0% |
| BRISTOL, LYNN ANNE | 2 | 63.6% | +39.7% |
| FREHE, WILLIAM R | 2 | 60.1% | +41.8% |
| ALLEN, MARIANNE P | 2 | 60.2% | +18.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18789085 | DRUG DELIVERY DEVICE | BOUCHELLE, LAURA A | — |
| 17846310 | SYRINGES, ASSEMBLIES, AND METHODS OF MANUFACTURE | BOUCHELLE, LAURA A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018389 | CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME | VAN BUREN, LAUREN K | 153d overdue |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 52d overdue |
| 18269015 | INTELLIGENT MITIGATION OR PREVENTION OF EQUIPMENT PERFORMANCE DEFICIENCIES | ISLAM, MOHAMMAD K | 36d overdue |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | HASTINGS, ALISON AZAR | 23d overdue |
| 18562107 | SOTORASIB DOSING REGIMEN | CHANDRAKUMAR, NIZAL S | 18d overdue |
| 17770320 | SYSTEMS AND COMPONENTS FOR DRUG DELIVERY AND COMPONENTS FOR PREPARATION OF THE SAME | KIM, ERIN ASA | 16d overdue |
| 17773892 | HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | SHELTON, SYNPHANE LA'SHAWN | 1d overdue |
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | FRITCHMAN, REBECCA M | 8d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042267 | ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION | BRISTOL, LYNN ANNE | 93d overdue |
| 17775257 | METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) | ALLEN, MARIANNE P | 87d overdue |
| 16586318 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | SKELDING, ZACHARY S | 77d overdue |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 52d overdue |
| 17641736 | Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity | HUYNH, PHUONG N | 16d |
| 18962768 | AUTOMATED SYSTEMS AND METHODS FOR FOIL PACKAGING COMPONENTS | TECCO, ANDREW M | — |
| 18845286 | PACKAGING FOR DRUG DELIVERY DEVICE | TECCO, ANDREW M | — |
| 18789085 | DRUG DELIVERY DEVICE | BOUCHELLE, LAURA A | — |
| Art Unit | Apps |
|---|---|
| 3783 | 21 |
| 1642 | 6 |
| 1641 | 6 |
| 1643 | 6 |
| 1674 | 5 |
| 1647 | 5 |
| 1644 | 5 |
| 1652 | 4 |
| 3731 | 3 |
| 1675 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19281019 | SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND | SIMMONS, CHRIS E | 1622 | DPOther | Final Rejection | 75d | Pending | Jul 25, 2025 |
| 19045308 | ROBOTIC SYSTEM FOR PERFORMING PATTERN RECOGNITION-BASED INSPECTION OF PHARMACEUTICAL CONTAINERS | RODRIGUEZ, JOSEPH C | 3653 | §103Other | Non-Final OA | — | Pending | Feb 04, 2025 |
| 19040481 | CONTAINERS AND SYSTEMS FOR USE DURING EXTERNAL STERILIZATION OF DRUG DELIVERY DEVICES | CASTELLANO, STEPHEN J | 3733 | §103 | Final Rejection | — | Pending | Jan 29, 2025 |
| 18878828 | ANTI-PD-1 ANTIBODY FORMULATIONS | OGUNBIYI, OLUWATOSIN A | — | §103§112 | Non-Final OA | — | Pending | Dec 24, 2024 |
| 18962768 | AUTOMATED SYSTEMS AND METHODS FOR FOIL PACKAGING COMPONENTS | TECCO, ANDREW M | 3731 | §102§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18934755 | SUSTAINABLE AND MODULAR PACKAGING SYSTEMS FOR CONTAINERS FOR PHARMACEUTICAL USE | ORTIZ, RAFAEL ALFREDO | 3736 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18855457 | COMPLEMENT-DEPENDENT CYTOTOXICITY METHODS | CURRENS, GRANT CARSON | — | §103 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18903590 | MANUFACTURING PROCESS FOR HOLLOW PLUNGER ROD | LEE, EDMUND H | 1744 | §112 | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18845286 | PACKAGING FOR DRUG DELIVERY DEVICE | TECCO, ANDREW M | 3731 | §103 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18842194 | A PROCESS FOR PREPARING 4-METHYL-2-PROPAN-2-YL-PYRIDINE-3-CARBONITRILE | RAHMANI, NILOOFAR | — | DP | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18807705 | MACHINE LEARNING (ML)-BASED SYSTEMS AND METHODS FOR PREDICTING DISEASE | EVANS, ASHLEY ELIZABETH | 3687 | §101 | Non-Final OA | 39d | Pending | Aug 16, 2024 |
| 18835139 | Visual Inspection Systems for Containers of Liquid Pharmaceutical Products | PEREZ-GUZMAN, CARLOS GABRIEL | 2877 | §102§103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18789085 | DRUG DELIVERY DEVICE | BOUCHELLE, LAURA A | — | §103 | Non-Final OA | — | Pending | Jul 30, 2024 |
| 18832887 | SYNTHESIS OF A KIF18A INHIBITOR | OH, TAYLOR V | — | §102 | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18730357 | Crystalline Forms Of An MCL-1 Inhibitor | SAMSELL, RILLA MARIE | — | §103 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18770259 | ASGR INHIBITORS | HOWARD, ZACHARY C | 1674 | §102§103§112 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18744036 | AUTOINJECTOR WITH SHOCK REDUCING ELEMENTS | MEDWAY, SCOTT J | — | §103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18718083 | ORAL SUSPENSION OF APREMILAST | BASQUILL, SEAN M | — | §103 | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18674549 | INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE | PATEL, SHEFALI DILIP | 3783 | §102§103 | Final Rejection | — | Pending | May 24, 2024 |
| 18704334 | DRUG DELIVERY DEVICES, COMPONENTS FOR USE WITHIN DRUG DELIVERY DEVICES, AND METHODS OF OPERATING DRUG DELIVERY DEVICES | BOSQUES, EDELMIRA | 3772 | §102§103§112 | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18697770 | CHARACTERIZATION APPARATUS FOR DRUG DELIVERY DEVICES OR SUBCOMPONENTS THEREOF | NATH, SUMAN KUMAR | 2855 | §101 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18696203 | Impact Activated Brake Feature for Drug Delivery Device | BOSQUES, EDELMIRA | — | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18696167 | IMPACT ACTIVATED RETENTION FEATURE FOR DRUG DELIVERY DEVICE | KASHYAP, ESHA PRAKASH | — | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18695688 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | KENYON, JOHN S | 1625 | §112 | Non-Final OA | — | Pending | Mar 26, 2024 |
| 18602268 | ANION EXCHANGE CHROMATOGRAPHY PROCESSES USING A PRIMARY AMINE LIGAND | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §102§103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18685037 | MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE | CHERNYSHEV, OLGA N | — | §112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18442665 | METHOD FOR PURIFYING PROTEINS | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18291294 | STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE | BAKSHI, PANCHAM | — | §112 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18577029 | SYSTEMS AND APPROACHES FOR DRUG PROCESSING USING SINGLE-USE HARDWARE | KUMAR, RAKESH | 3651 | §103§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18574161 | METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION | BANERJEE, KOYELI | 1658 | §103 | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18569735 | SAFETY DEVICE FOR DRUG DELIVERY SYSTEM | DARB, HAMZA A. | 3783 | §103 | Final Rejection | — | Pending | Dec 13, 2023 |
| 18538279 | ANTIBODY CONSTRUCTS FOR MSLN AND CD3 | BRISTOL, LYNN ANNE | — | DP | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18535068 | FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME | LANDSMAN, ROBERT S | 1647 | §103Other | Non-Final OA | 21d | Pending | Dec 11, 2023 |
| 18525039 | METHODS OF ANTIBODY PRODUCTION | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | 70d | Pending | Nov 30, 2023 |
| 18564675 | LYOPHILIZATION SYSTEM/LYOPHILIZER | WAN, DEMING | 3762 | §103 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18562107 | SOTORASIB DOSING REGIMEN | CHANDRAKUMAR, NIZAL S | 1625 | §101§103Other | Non-Final OA | 18d overdue | Pending | Nov 17, 2023 |
| 18503009 | DOSING REGIMEN OF KRAS G12C INHIBITOR | AULAKH, CHARANJIT | 1621 | §102Other | Non-Final OA | 26d overdue | Pending | Nov 06, 2023 |
| 18558827 | SOTORASIB FORMULATION | GOTFREDSON, GAREN | 1619 | §103 | Final Rejection | — | Pending | Nov 03, 2023 |
| 18289317 | DOSING REGIMEN FOR COMBINATION THERAPY TARGETING DLL3 AND PD-1 | DUTT, ADITI | 1675 | DP | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18288549 | METHOD OF OPTIMIZING A FILLING RECIPE FOR A DRUG CONTAINER | SEIF, DARIUSH | 3731 | §103 | Non-Final OA | 29d | Pending | Oct 26, 2023 |
| 18287593 | ANTI-TSLP ANTIBODY COMPOSITIONS AND USES THEREOF | MIDDLETON, DANAYA L | 1674 | DP | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18285125 | MAGEB2 BINDING CONSTRUCTS | JOHANSEN, PETER N. | 1644 | §112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18284590 | MODULATING PRODUCT QUALITY OF ASYMMETRIC MULTISPECIFIC ANTIBODIES THROUGH THE USE OF TEMPERATURE | AEDER, SEAN E | 1642 | §103§112 | Final Rejection | — | Pending | Sep 28, 2023 |
| 18550647 | DRUG DELIVERY DEVICE | FREHE, WILLIAM R | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18550645 | COMPONENT MATCHING DECISION SUPPORT TOOL | CARTER, CHRISTOPHER W | 2117 | §102 | Final Rejection | — | Pending | Sep 14, 2023 |
| 18550650 | SOUND-DETECTION BASED INJECTION TIME MEASUREMENT SYSTEM FOR DRUG DELIVERY DEVICES | FREHE, WILLIAM R | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18367580 | Just-In-Time Learning With Variational Autoencoder For Cell Culture Process Monitoring And/Or Control | HARTMAN JR, RONALD D | 2119 | §103 | Non-Final OA | — | Pending | Sep 13, 2023 |
| 18241564 | LEAN PERFUSION CELL CULTURE METHODS | BARRON, SEAN C | 1653 | §103 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18275550 | SYSTEMS AND APPROACHES FOR DRUG PROCESSING | WRIGHT, PATRICIA KATHRYN | 1798 | §102 | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18357495 | RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION | YU, DAVID TUYANG | 1635 | §103 | Non-Final OA | 71d | Pending | Jul 24, 2023 |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | HASTINGS, ALISON AZAR | 1627 | §102§103Other | Final Rejection | 23d overdue | Pending | Jun 30, 2023 |
| 18269015 | INTELLIGENT MITIGATION OR PREVENTION OF EQUIPMENT PERFORMANCE DEFICIENCIES | ISLAM, MOHAMMAD K | 2857 | §101§103 | Non-Final OA | 36d overdue | Pending | Jun 22, 2023 |
| 18268772 | METHODS FOR PURIFICATION OF RECOMBINANT PROTEINS | LIMBAUGH, KATHRYN ELIZABETH | 1797 | §103§112 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18333607 | Methods of Manufacturing Biological Therapies | DICKINSON, PAUL W | 1618 | §101§103 | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18038283 | MAGE-B2-SPECIFIC T-CELL RECEPTORS | DARPOLOR, JOSEPHINE KEBBEH | 1642 | §112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18038041 | COMPUTER SURROGATE MODEL TO PREDICT THE SINGLE-PHASE MIXING QUALITY IN STEADY STATE MIXING TANKS | RUTTEN, JAMES D | 2121 | §103 | Final Rejection | 23d overdue | Pending | May 22, 2023 |
| 18037128 | REAL TIME PCR METHOD TO DETECT BOVINE PARVOVIRUS 3 | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Non-Final OA | — | Pending | May 16, 2023 |
| 18035016 | METHODS FOR DECREASING MORTALITY RISK AND IMPROVING HEALTH | ALABI, OYELEYE A | 1797 | §101§103 | Non-Final OA | 23d | Pending | May 02, 2023 |
| 18032765 | DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE | RADOMSKI, MARTIN ADAM | 3783 | §103 | Final Rejection | — | Pending | Apr 19, 2023 |
| 18031691 | RELATIVE UNPAIRED GLYCANS IN ANTIBODY PRODUCTION METHODS | ROBINSON, HOPE A | 1652 | §103§112DP | Final Rejection | — | Pending | Apr 13, 2023 |
| 18248345 | RATIONAL SELECTION OF BUILDING BLOCKS FOR THE ASSEMBLY OF MULTISPECIFIC ANTIBODIES | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18296211 | AMORPHOUS AND CRYSTALLINE FORMS OF MCL-1 ANTAGONISTS | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §102§112 | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18026678 | METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS | ARMATO JR, DENNIS IGNATIUS | 1651 | §102§103§112 | Non-Final OA | 33d | Pending | Mar 16, 2023 |
| 18025311 | Predicting Shelf Life Stability of Lyophilized Drug Products | TAMIRU, ABRHAM ALEHEGN | 2188 | §101§103 | Non-Final OA | — | Pending | Mar 08, 2023 |
| 18024893 | METHOD OF MAKING LYOPHILIZED PROTEIN FORMULATIONS | ROSSI, JULIA ANNE LORRAIN | 1674 | §103§112DP | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18044158 | MATERIALS AND METHODS TO REDUCE PROTEIN AGGREGATION | ALLEN, MARIANNE P | 1647 | §103 | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18178086 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | STONEBRAKER, ALYSSA RAE | 1642 | §112Other | Non-Final OA | 8d overdue | Pending | Mar 03, 2023 |
| 18022685 | PHARMACEUTICAL FORMULATION | HUYNH, PHUONG N | 1641 | §103§112 | Final Rejection | — | Pending | Feb 22, 2023 |
| 18042267 | ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION | BRISTOL, LYNN ANNE | 1643 | §112 | Final Rejection | 93d overdue | Pending | Feb 20, 2023 |
| 18018389 | CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME | VAN BUREN, LAUREN K | 1638 | §103§112 | Final Rejection | 153d overdue | Pending | Jan 27, 2023 |
| 18007126 | Selecting Resins for Use in Chromatography Purification Processes | BICKHAM, DAWN MARIE | — | §101§102§103 | Non-Final OA | — | Pending | Jan 27, 2023 |
| 18097725 | SYSTEMS AND METHODS FOR DELAYED DRUG DELIVERY | ZAMORY, JUSTIN L | 3783 | §103 | Final Rejection | 44d overdue | Pending | Jan 17, 2023 |
| 18002303 | METHODS OF MEASURING CARFILZOMIB | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 18009682 | CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | RODRIGUEZ, RAYNA B | 1628 | §103Other | Final Rejection | — | Pending | Dec 09, 2022 |
| 18007560 | RNAI CONSTRUCTS FOR INHIBITING HSD17B13 EXPRESSION AND METHODS OF USE THEREOF | SHIN, DANA H | 1635 | §103§112 | Final Rejection | — | Pending | Dec 01, 2022 |
| 18072959 | INTERLEUKIN-21 MUTEIN/ ANTI-PD-1 ANTIBODY CONJUGATES | ABBAS, SYED JARAR | 1674 | — | Non-Final OA | — | Pending | Dec 01, 2022 |
| 17928561 | ANTIBODY FORMULATIONS AND USES THEREOF | KIM, YUNSOO | 1641 | §103DP | Final Rejection | 85d overdue | Pending | Nov 29, 2022 |
| 18054426 | ANTI-STEAP1 ANTIGEN-BINDING PROTEIN | MOSELEY II, NELSON B | 1642 | §112 | Non-Final OA | — | Pending | Nov 10, 2022 |
| 17923347 | Deep Learning Platforms for Automated Visual Inspection | HICKS, AUSTIN JAMES | 2142 | §102§103 | Final Rejection | 22d | Pending | Nov 04, 2022 |
| 17774125 | METHODS FOR TREATING LEUKEMIA | BENAVIDES, JENNIFER ANN | 1675 | §103§112Other | Non-Final OA | 12d | Pending | Oct 31, 2022 |
| 17921794 | PHARMACEUTICAL FORMULATION | SKELDING, ZACHARY S | 1644 | §112Other | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17920668 | SELECTING CHROMATOGRAPHY PARAMETERS FOR MANUFACTURING THERAPEUTIC PROTEINS | KALLAL, ROBERT JAMES | 1685 | §101§103 | Non-Final OA | — | Pending | Oct 21, 2022 |
| 18046860 | ACTIVATABLE POLYPEPTIDE COMPLEX | LOCKARD, JON MCCLELLAND | 1647 | §103§112Other | Non-Final OA | 34d | Pending | Oct 14, 2022 |
| 17910653 | DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE | MISHRA, DEEPA | 1657 | §103§112 | Non-Final OA | 27d | Pending | Sep 09, 2022 |
| 17930810 | ADAPTATION OF PLATFORM HOSTS TO IGF- MEDIA | VIVLEMORE, TRACY ANN | 1638 | §102§103§112 | Final Rejection | — | Pending | Sep 09, 2022 |
| 17821835 | Method of Antigen-Binding Protein Production | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Non-Final OA | 182d overdue | Pending | Aug 24, 2022 |
| 17810142 | STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | — | Pending | Jun 30, 2022 |
| 17846310 | SYRINGES, ASSEMBLIES, AND METHODS OF MANUFACTURE | BOUCHELLE, LAURA A | 3783 | §103 | Non-Final OA | — | Pending | Jun 22, 2022 |
| 17834518 | METHODS OF PROTEIN CLIPS RECOVERY | CHIN, CHRISTOPHER L | 1677 | §112DP | Non-Final OA | — | Pending | Jun 07, 2022 |
| 17780596 | FLOW RESTRICTOR FOR DRUG DELIVERY DEVICE | THOMAN, EVELYN ANNE | 3783 | §103§112 | Final Rejection | — | Pending | May 27, 2022 |
| 17776622 | HEMATOPOIETIC PRECURSOR CELL PRODUCTION | PRONZATI, GINA | 1633 | §112 | Non-Final OA | — | Pending | May 13, 2022 |
| 17775520 | DOSING REGIMEN FOR ANTI-DLL3 AGENTS | BERHANE, SELAM | 1675 | §103 | Final Rejection | 4d overdue | Pending | May 09, 2022 |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 1644 | §103§112 | Final Rejection | 52d overdue | Pending | May 09, 2022 |
| 17775257 | METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) | ALLEN, MARIANNE P | 1647 | §103DP | Final Rejection | 87d overdue | Pending | May 06, 2022 |
| 17774232 | MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES | KAUFMAN, CLAIRE M | 1674 | §102§103§112 | Non-Final OA | — | Pending | May 04, 2022 |
| 17773892 | HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | SHELTON, SYNPHANE LA'SHAWN | 1652 | §102§103 | Final Rejection | 1d overdue | Pending | May 03, 2022 |
| 17773886 | HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | DEBERRY, REGINA M | 1647 | DP | Final Rejection | 88d overdue | Pending | May 03, 2022 |
| 17770320 | SYSTEMS AND COMPONENTS FOR DRUG DELIVERY AND COMPONENTS FOR PREPARATION OF THE SAME | KIM, ERIN ASA | 3781 | §102§103§112 | Non-Final OA | 16d overdue | Pending | Apr 20, 2022 |
| 17767466 | NEEDLE INSERTION MECHANISM FOR DRUG DELIVERY DEVICE | WITTLIFF, KATERINA ANNA | 3783 | §103 | Final Rejection | — | Pending | Apr 08, 2022 |
| 17767462 | CASSETTE FOR AN AUTOINJECTOR AND RELATED METHODS | VOKES, KATHLEEN PAIGE | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17763824 | METHODS OF PRODUCING ANTIBODY COMPOSITIONS | IVICH, FERNANDO NMN | 1678 | §112 | Final Rejection | 7d | Pending | Mar 25, 2022 |
| 17763677 | SYSTEMS AND APPROACHES FOR DRUG DELIVERY DEVICE RECONSTITUTION | HAN, SETH | 3781 | §103 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17702131 | V-C-FC-V-C ANTIBODY | SHUPE, ELIZABETH A | 1643 | §103§112 | Final Rejection | — | Pending | Mar 23, 2022 |
| 17697632 | BISPECIFIC FC MOLECULES | FAUST, AMBER KATHLEEN | 1643 | §103 | Final Rejection | — | Pending | Mar 17, 2022 |
| 17641736 | Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | 16d | Pending | Mar 09, 2022 |
| 17637520 | ACTIVATABLE INJECTION DEVICE FOR DRUG DELIVERY | DANIEL, ANTARIUS S | 3783 | §102 | Non-Final OA | — | Pending | Feb 23, 2022 |
| 17621135 | Wireless Communication Enabled Drug Delivery Device and Method | PAZ ESTEVEZ, GUILLERMO G | 3783 | §102§103 | Non-Final OA | — | Pending | Dec 20, 2021 |
| 17616580 | BISPECIFIC BINDING CONSTRUCTS | MELCHIOR, JAMES RYLAND | 1644 | §103DP | Final Rejection | — | Pending | Dec 03, 2021 |
| 17616234 | AUTOMATED BIOMASS-BASED PERFUSION CONTROL IN THE MANUFACTURING OF BIOLOGICS | JOHNSON, KARA D | 1632 | §102§103§112 | Non-Final OA | 79d | Pending | Dec 03, 2021 |
| 17537922 | AUTOINJECTOR WITH STALL AND END POINT DETECTION | ALLEN, ROBERT F | 3783 | §103 | Non-Final OA | — | Pending | Nov 30, 2021 |
| 17615520 | RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF | SULLIVAN, STEPHANIE LAUREN | 1635 | DP | Final Rejection | 1d overdue | Pending | Nov 30, 2021 |
| 17514763 | PLUNGERS FOR DRUG DELIVERY DEVICES | RITCHIE, HADEN MATTHEW | 3783 | §103 | Final Rejection | — | Pending | Oct 29, 2021 |
| 17602148 | DRUG DELIVERY DEVICE WITH SMART GRIP | DIOP, FATIMATA SAHRA | 3783 | §102§103 | Non-Final OA | — | Pending | Oct 07, 2021 |
| 17599028 | USE OF ONCOLYTIC VIRUSES IN THE NEOADJUVANT THERAPY OF CANCER | ROGERS, ERIC JASON | 1638 | §102§103§112 | Non-Final OA | — | Pending | Sep 28, 2021 |
| 17441021 | INJECTOR ACCESSORIES | FARRAR, LAUREN PENG | 3783 | §103 | Final Rejection | — | Pending | Sep 20, 2021 |
| 17440906 | SYRINGE STERILIZATION VERIFICATION ASSEMBLIES AND METHODS | DIPERT, FORREST BLAKE | 3783 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2021 |
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | 8d | Pending | Sep 03, 2021 |
| 17426194 | CONTINUOUS DOSING SYSTEMS AND APPROACHES | DIPERT, FORREST BLAKE | 3783 | §103 | Non-Final OA | — | Pending | Jul 28, 2021 |
| 17277533 | PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Final Rejection | 65d | Pending | Mar 18, 2021 |
| 17264139 | INTERVENTIONAL DOSING SYSTEMS AND METHODS | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Non-Final OA | 4d overdue | Pending | Jan 28, 2021 |
| 17036690 | DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103 | Non-Final OA | 22d | Pending | Sep 29, 2020 |
| 16964452 | LOW PH PHARMACEUTICAL ANTIBODY FORMULATION | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | 21d | Pending | Jul 23, 2020 |
| 16771641 | METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM | DABKOWSKI, ERINNE R | 1654 | §102§112 | Non-Final OA | — | Pending | Jun 10, 2020 |
| 16763515 | METHODS FOR PRODUCING PROTEIN PRODUCTS | HURST, JONATHAN M | 1799 | §103 | Final Rejection | 162d overdue | Pending | May 12, 2020 |
| 13931716 | METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS | WEN, SHARON X | 1641 | Other | Final Rejection | 18d overdue | Pending | Jun 28, 2013 |
| 18430415 | BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3 | NATARAJAN, MEERA | — | §112DP | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18556998 | METHODS FOR REDUCING LOW MOLECULAR WEIGHT SPECIES OF RECOMBINANTLY-PRODUCED PROTEINS | SZPERKA, MICHAEL EDWARD | 1641 | §102§103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18164304 | TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | DUFFY, BRADLEY | 1643 | §102§103§112DP | Non-Final OA | — | Pending | Feb 03, 2023 |
| 18066972 | CROSS-SPECIES-SPECIFIC BINDING DOMAIN | DUFFY, BRADLEY | 1643 | §102DP | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17932739 | TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA | HOLTZMAN, KATHERINE ANN | 1646 | §103§112DP | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17775543 | DOSAGE REGIMEN FOR ANTI-EGFRVIII AGENTS | CHASE, CAROL ANN | 1646 | §103§112DP | Non-Final OA | 86d overdue | Pending | May 09, 2022 |
| 17605061 | MEANS AND METHODS FOR TREATING BURKITT LYMPHOMA OR LEUKEMIA | WU, JULIE ZHEN QIN | 1643 | Other | Final Rejection | 43d | Pending | Oct 20, 2021 |
| 17480504 | Means and Methods for Treating Tumorous Diseases | MOSELEY II, NELSON B | 1642 | §103 | Final Rejection | — | Pending | Sep 21, 2021 |
| 16586318 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | SKELDING, ZACHARY S | 1644 | §112 | Non-Final OA | 77d overdue | Pending | Sep 27, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial